Related Experiment Video
Updated: Jan 15, 2026

09:29
Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
7.8K
401-Gene Signature of Myocardial Dysfunction in Human Heart Failure: A Transcriptomic Analysis.
Kiki J Estes-Schmalzl1, Amy J Marcano-Reik1, Kristin M Lefebvre1
1Clinical Research, University of Jamestown, Fargo, USA.
Cureus
|October 9, 2025
Summary
Researchers identified a 401-gene signature in heart failure, revealing key molecular changes in myocardial tissue. This discovery aids in developing new biomarkers and targeted therapies for heart failure patients.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Genomics
Background:
- Heart failure (HF) is a major global health issue, driven by complex molecular remodeling of the heart muscle.
- Transcriptomic analysis is crucial for uncovering disease-specific gene expression patterns and potential therapeutic targets in HF.
Purpose of the Study:
- To identify a comprehensive gene expression signature in heart failure using transcriptomic data.
- To explore the molecular mechanisms underlying heart failure pathophysiology and identify potential therapeutic targets.
Main Methods:
- Analysis of publicly available gene expression data (GEO dataset GSE57345) from left ventricular tissue.
- Differential gene expression analysis using limma with Benjamini-Hochberg correction.
- Pathway enrichment analysis to identify dysregulated biological processes.
Main Results:
- Identification of 401 significantly differentially expressed genes (401-gene signature) in heart failure samples.
- Balanced gene dysregulation observed, with 198 genes upregulated and 203 genes downregulated.
- Enrichment in pathways related to mitochondrial dysfunction, immune activation, and extracellular matrix remodeling.
Conclusions:
- The 401-gene signature offers insights into heart failure molecular mechanisms.
- This signature can serve as a resource for developing heart failure biomarkers and therapeutic targets.
- The findings support precision medicine strategies for HF diagnosis and treatment stratification.
Related Concept Videos
Pathophysiology of Heart Failure
2.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.9K
Heart Failure II: Pathophysiology
722
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
722
Cardiomyopathy III: Hypertrophic Cardiomyopathy
401
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
401
Heart Failure I: Introduction
693
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
693

